BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19115486)

  • 1. Primary cerebral diffuse large B-cell lymphoma relapsed solely in the skin with the same clonal origin.
    Chuang SS; Liu H; Huang Y; Chio CC; Lin LC
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):77-81. PubMed ID: 19115486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas.
    Choi JS; Nam DH; Ko YH; Seo JW; Choi YL; Suh YL; Ree HJ
    Am J Surg Pathol; 2003 Jul; 27(7):919-28. PubMed ID: 12826884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival.
    Fernández-Vázquez A; Rodríguez-Peralto JL; Martínez MA; Platón EM; Algara P; Camacho FI; López-Ríos F; Zarco C; Sánchez-Yus E; Fresno MF; Barthe L; Aliaga A; Fraga M; Forteza J; Oliva H; Piris MA
    Am J Surg Pathol; 2001 Mar; 25(3):307-15. PubMed ID: 11224600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
    Wehkamp U; Pott C; Unterhalt M; Koch K; Weichenthal M; Klapper W; Oschlies I
    Am J Surg Pathol; 2015 Aug; 39(8):1093-101. PubMed ID: 26034867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous diffuse large B cell lymphoma relapsed solely as a huge lung tumor mimicking a primary pulmonary lymphoma.
    Chen YF; Li YC; Chen LM; Tu CC; Chang CC; Kuo SY; Lin SH; Chuang SS
    Int J Hematol; 2010 Jan; 91(1):112-6. PubMed ID: 20012513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.
    Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD
    Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system lymphoma: a clinicopathological study of 75 cases.
    Preusser M; Woehrer A; Koperek O; Rottenfusser A; Dieckmann K; Gatterbauer B; Roessler K; Slavc I; Jaeger U; Streubel B; Hainfellner JA; Chott A
    Pathology; 2010; 42(6):547-52. PubMed ID: 20854073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis.
    Dogan A; Burke JS; Goteri G; Stitson RN; Wotherspoon AC; Isaacson PG
    Am J Surg Pathol; 2003 Jul; 27(7):903-11. PubMed ID: 12826882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary cutaneous diffuse large B-cell lymphoma, leg type: a study of clinicopathology, immunophenotype and gene rearrangement].
    Wang T; Jia L; Liao W; Chen L; Chen X; Xiong Y; Hao F; Zhu X; Yang X; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):100-5. PubMed ID: 25916640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
    Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
    Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.
    Lin CH; Kuo KT; Chuang SS; Kuo SH; Chang JH; Chang KC; Hsu HC; Tien HF; Cheng AL
    Clin Cancer Res; 2006 Feb; 12(4):1152-6. PubMed ID: 16489068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous metastasis of primary diffuse large B-cell lymphoma of the central nervous system developing 4 years after complete remission: Diagnosis confirmed by comparison of clones.
    Patel BM; Moesch J; Karunamurthy A; Puleio DV; Drappatz J; Akilov OE; Kazlouskaya V
    J Cutan Pathol; 2022 Jan; 49(1):90-94. PubMed ID: 34498750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution.
    Xerri L; Adélaïde J; Avenin M; Guille A; Taix S; Bonnet N; Carbuccia N; Garnier S; Mescam L; Murati A; Chaffanet M; Coso D; Bouabdallah R; Bertucci F; Birnbaum D
    Histopathology; 2019 Mar; 74(4):654-662. PubMed ID: 30393995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinicopathological study of primary central nervous system lymphomas & their association with Epstein-Barr virus.
    Sharma MC; Gupta RK; Kaushal S; Suri V; Sarkar C; Singh M; Kale SS; Sahoo RK; Kumar L; Raina V
    Indian J Med Res; 2016 May; 143(5):605-15. PubMed ID: 27488004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of B Cell Differentiation Markers on the Prognosis of Primary Central Nervous System Lymphoma].
    Chen XL; Li XY; Wang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1410-1414. PubMed ID: 29070116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization.
    Yang B; Tubbs RR; Finn W; Carlson A; Pettay J; Hsi ED
    Am J Surg Pathol; 2000 May; 24(5):694-702. PubMed ID: 10800988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous large B-cell lymphoma of atypical presentation: case report.
    Sousa AR; Costa IS; Araujo Filho EF; Jucá NB; Miranda WL
    An Bras Dermatol; 2011; 86(3):549-51. PubMed ID: 21738974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous spindle-cell B-cell lymphoma: a morphologic variant of cutaneous large B-cell lymphoma.
    Cerroni L; El-Shabrawi-Caelen L; Fink-Puches R; LeBoit PE; Kerl H
    Am J Dermatopathol; 2000 Aug; 22(4):299-304. PubMed ID: 10949453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.